Blue Jet Healthcare Limited (NSE:BLUEJET)

India · Delayed Price · Currency is INR

376.10

+0.50 (0.13%)

At close: Mar 10, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Artificial Sweetener, Contrast Media Intermediate, Pharma Intermediate, APls	10.30B	7.12B	7.21B	6.83B	4.99B
Artificial Sweetener, Contrast Media Intermediate, Pharma Intermediate, APls Growth	44.74%	-1.30%	5.49%	36.99%	-7.30%
Total	10.30B	7.12B	7.21B	6.83B	4.99B
Total Growth	44.74%	-1.30%	5.49%	36.99%	-7.30%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Norway	3.49B	4.02B	4.57B	4.26B	-
Norway Growth	-13.18%	-12.06%	7.28%	-	-
India	1.32B	933.12M	1.00B	1.16B	716.55M
India Growth	41.78%	-6.86%	-13.61%	61.84%	18.81%
Rest of The World	1.09B	1.17B	1.61B	1.35B	-
Rest of The World Growth	-6.84%	-27.26%	19.63%	-	-
France	4.34B	958.98M	-	-	-
France Growth	352.76%	-	-	-	-
Europe	-	-	-	-	3.94B
Europe Growth	-	-	-	-	-11.12%
USA	-	-	-	-	170.13M
USA Growth	-	-	-	-	35.40%
Others	-	-	-	-	115.23M
Others Growth	-	-	-	-	-13.61%
Total	10.25B	7.08B	7.18B	6.77B	4.94B
Total Growth	44.65%	-1.40%	6.16%	36.94%	-6.67%

Source: S&P Global Market Intelligence.